Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01296672 · ClinicalTrials.gov registry record · Phase 4
3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer
A Phase 4 study, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- Phase 4
- Development phase
- 383
- Enrollment target
NCT01296672 is a Phase 4 study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 383 participants.
The verdict
NCT01296672, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 383 participants
- Enrollment target
Study Summary
The investigators will propose a novel method to improve prostate cancer screening with PSA, using a 3-month treatment with finasteride, a drug used to treat Benign Prostatic Hyperplasia (BPH) and proven to reduce a man's risk of developing prostate cancer. The investigators will also examine three additional promising tests that may further improve diagnosis of prostate cancer.
Interventions
- DRUG Placebo
- DRUG Finasteride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 383 participants |
| Start Date | 2011-02 |
| Est. Completion | 2017-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01296672
The ClinicalTrials.gov registry entry for NCT01296672 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 383 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01296672 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01296672 about?
NCT01296672 is a clinical study titled "3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer". The investigators will propose a novel method to improve prostate cancer screening with PSA, using a 3-month treatment with finasteride, a drug used to treat Benign Prostatic Hyperplasia (BPH) and proven to reduce a man's risk of developing prostate cancer. The investigators will also examine three ...
What is the current status of trial NCT01296672?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 383 participants. The study started on 2011-02. Estimated completion is 2017-01.
What interventions are being tested in trial NCT01296672?
The interventions under investigation include: Placebo (DRUG), Finasteride (DRUG).
Who is sponsoring clinical trial NCT01296672?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.